JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Surgery Section DOI : 10.7860/JCDR/2015/13144.6737
Year : 2015 | Month : Nov | Volume : 9 | Issue : 11 Full Version Page : PC04 - PC08

Small Bowel Carcinoids: A Single Surgeon’s Experience in Southern India

Sreevathsa Maddibande Ramachar1, Nishchit Hegde2

1 Senior Professor & Unit Head, Department of General Surgery, MS Ramaiah Medical College and Hospital, Mathikere, Bangalore, India.
2 Resident, Department of General Surgery, MS Ramaiah Medical College and Hospital, Mathikere, Bangalore, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Sreevathsa Maddibande Ramachar, Senior Professor & Unit Head, Department of General Surgery, MS Ramaiah Medical College And Hospital, Msr Nagar, Msrit Post, Mathikere, Bangalore-560054, India.
E-mail: chee_vaccha@yahoo.co.in, nishchithegde@gmail.com
Abstract

Introduction

Small bowel carcinoid tumours are indolent neuroendocrine tumours usually seen in the 6th and 7th decades. Most often, they are silent with non-specific symptoms. They generate serotonin, provoking a desmoplastic reaction in the mesentery leading to bowel ischemia and obstruction. While CECT abdomen can help raise suspicion and show regional spread, elevated 24-hour urinary 5-HIAA levels, histopathology and immunohistochemistry for Chromogranin A are confirmatory.

Aim

To analyse a single surgeon’s experience of clinical features and diagnosis of carcinoid tumours of the small intestine.

Setting and Design

Retrospective study conducted at MS Ramaiah Medical College and Hospital, Bangalore, India.

Materials and Methods

Fourteen cases of carcinoid of the small bowel presenting to our institution over a 9-year period between December 2005 and November 2014 comprised the study. This included 10 males to 4 females aged 43 to 67 years (Mean: 54.4 years). The patients were investigated using x-ray abdomen, barium study, CECT abdomen, colonoscopy and 24-hour urinary 5- HIAA levels. All patients were surgically treated and histological examination of the redivted tumours and immunohistochemistry for Chromogranin A was performed.

Results

Twelve patients with ileal carcinoids presented with long standing intestinal colic and sub-acute obstruction. Two patients with jejunal carcinoids had epigastric pain. X-ray abdomen was suggestive of small bowel obstruction in 12 patients. CECT abdomen done in 6 patients, showed ileal narrowing causing proximal dilatation; and cocooining of ileal loops at ileo-caecal junction in 2 cases. Ten patients underwent segmental redivtion-anastomosis of the tumour-bearing intestine while 4 patients underwent a right hemicolectomy. Lymph node spread was seen in 8 patients of whom 4 had liver metastases. Histopathology and Chromogranin A positivity confirmed the diagnoses. Postoperatively, 24-hour urinary 5-HIAA was mildly elevated in 2 patients. 12 patients were disease free at mean follow up of 4.3 years. 2 patients died due to inanition at 3 and 5 months postoperatively.

Conclusion

Carcinoid tumours of small intestine are uncommon in southern India. But they should be considered as differential diagnosis when intestinal tuberculosis is suspected in the elderly presenting with intestinal colic or sub-acute obstruction. They are associated with good prognosis after adequate redivtion.

Keywords

Carcinoid tumours,Ileal carcinoids,Neuroendocrine tumours,Small intestinal obstruction

Introduction

Neuroendocrine tumours are uncommon tumours arising from ‘neuroendocrine cells’ in the body. These cells have their origin in the neuroectoderm. Otto Lubarsch, in 1888, first described carcinoid tumours when he reported 2 patients with ileal carcinoids discovered at autopsy [1]. In 1907, Siegfried Obendorfer, a German pathologist at the University of Munich, coined the term ‘Karzinoide’ or carcinoma-like to describe the tumour which appeared malignant on histology but behaved in a more benign fashion [2]. Recognition of endocrine properties of these tumours came to light when Rapport and his colleagues isolated serotonin (5 HT) in 1952 [3]. Carcinoid tumours were found to arise from Kulchitsky or Enterochromaffin cells, which are part of the diffuse neuroendocrine system of the gastrointestinal tract. Lembeck identified serotonin in ileal carcinoids a year later in 1953 [4].

While no reliable epidemiological data is available describing the prevalence of carcinoid tumours in India, the estimated incidence of these rare tumours is about 5.25 per 100,000 people [5] accounting for just 0.66% of all malignancies in the west [6]. The incidence is likely to be falsely low in our country as accurate diagnostic facilities remain out of reach of the majority of the population, symptoms being non-specific and therefore the tendency of patients to present late in the course of the disease.

Most carcinoids arise in the gastrointestinal tract (55%) and broncho-pulmonary system (30%) [7]. The commonest location for these tumours is the small bowel [8] with nearly half of these (45%) occurring in the distal ileum [9]. Small bowel carcinoids present in the 6th to 7th decade [10] and up to 30% of these lesions are multiple [11]. Patients typically present with abdominal pain and/or sub-acute intestinal obstruction, which is due to the desmoplastic reaction in the mesentery leading to kinking of small bowel or direct luminal narrowing. Confirmation of diagnosis is based on histopathology with additional help from immunohistochemistry for Chromogranin A [12]. The extent of disease determines the 5-year survival, which is 65% for loco-regional disease [13]. There is paucity of data on small bowel carcinoids in our country, especially in the south Indian population. This study not only describes the symptoms and management of carcinoid tumours, but more importantly includes a sufficiently long follow up period as well.

Materials and Methods

A review of our hospital medical records in the study period showed 30 cases of small bowel tumours treated in the last 9 years. Of these 30 cases, 14 were carcinoids accounting for 46.6% of all small bowel tumours. The remaining included 10 cases of Gastrointestinal stromal tumour (GIST), 4 cases of lymphoma and 2 cases of adenocarcinoma. In total, 14 patients diagnosed with small bowel carcinoids, ten male and four female presenting to the Department of General Surgery at M.S. Ramaiah Medical Teaching Hospital over a period of 9 years from December 2005 to November 2014 were considered for the study [Table/Fig-1]. Their ages ranged from 43 to 67 years (Mean age: 54.4 years).

Distribution of small bowel carcinoids

Carcinoid siteNumber% of TotalMale:FemaleStage% of TotalMortality
Jejunum214.32:0T3N0M0 = 214.3NIL
Ileum1285.710:2T3N0M0 = 428.6NIL
T3N1M0 = 428.61
T3N1M1 = 428.61

All the patients were symptomatic. The duration of symptoms varied from 1.5 to 10 years (Mean duration: 7 years). Intestinal colic was the commonest symptom in 12 out of 14 patients; two patients with jejunal carcinoids had epigastric pain mimicking peptic ulcer disease of 10 years duration. Twelve patients presented with intermittent sub-acute intestinal obstruction of nearly one and a half years duration after having non-specific abdominal symptoms for few years. Eight patients had significant loss of weight. Clinical findings were of mildly distended abdomen with intermittent borborgymi in those with sub-acute obstruction (12 patients) of which two patients had an ill-defined lower abdominal mass in the right iliac fossa and hypogastrium. In the remaining 2, there were no abdominal findings [Table/Fig-2].

Symptoms and signs

Carcinoid SiteSymptomsClinical Examination
Epigastric PainIntestinal ColicFeatures of Intermittent SAIOAbdominal DistentionIntestinal BorborgymiAbdominal MassNone
Jejunum2-----2
Ileum-121212122-

All patients underwent X-ray abdomen in erect and supine views showing dilated jejunal coils in 12 patients with sub-acute intestinal obstruction (SAIO). Eight patients underwent thin barium study of the small bowel. Eight patients had a Computed Tomography (CT) Scan Abdomen with oral and IV contrast. The remaining could not afford a CT Scan. Oesophagogastroduodenoscopy (OGD) was performed in two patients in whom acid peptic disease was suspected. Colonoscopy was done in 2 patients.

Twelve patients with SAIO underwent laparotomy and two patients with epigastric pain underwent a laparoscopy-assisted procedure. All tumour specimens were analysed histologically and immunohistochemically for Chromogranin A activity after the histological diagnosis of carcinoid tumour was made. Postoperatively 24 hour urinary 5-hydroxy indole acetic acid (5HIAA) level was assessed in all the patients. All patients included in the study were regularly followed up. The study was approved by the Academic & Institutional Ethical Committee of MS Ramaiah Medical College.

Results

Fourteen patients of small bowel carcinoid tumours were included in the study after review of medical records. Along with the clinical features mentioned earlier in methodology, X-Ray abdomen was suggestive of small intestinal obstruction in 12 patients. In 8 patients in whom it was performed, barium study showed dilated loops of small intestine in all. In the contrast enhanced CT (CECT) abdomen of 6 patients, small bowel (ileal) narrowing with proximal dilatation was seen. In two, cocooning of ileal loops at the ileo-caecal junction was seen, along with mesenteric lymph node enlargement but there were no findings suggestive of carcinoid [Table/Fig-3,4]. Colonoscopy performed in 2 patients showed features of large bowel obstruction at the ileo-caecal junction. Oesophagogastroduodenoscopy of the 2 patients with epigastric pain was normal. Based on the clinical and radiological features, the pre-operative diagnosis considered was stricture of the ileum probably due to tuberculosis in 8 patients, caecal carcinoma in two and acid peptic disease in two other patients with jejeunal carcinoids who had abdominal symptoms for the preceding 8 to 10 years. In the two patients presenting more recently in the series, a small bowel GIST was suspected on clinical grounds due to the ill-defined mass felt per abdominally in them and the presence of ileo-caecal obstruction. In none, a preoperative diagnosis of carcinoid of small bowel was entertained [Table/Fig-5].

CT Abdomen showing spiculated masss (arrow) arising from distal ileum

Mesenteric lymph node enlargement on CT abdomen (arrow heads)

Preoperative investigations and diagnoses

Carcinoid SitePre-operative DiagnosisPre-operative investigations
Abdominal X Ray (all 14 patients) (All 14 Patients)Barium Study (8 Patients)CECT Abdomen (8 Patients)Esophago-Gastro-Duodenoscopy (2 Patients)Colonoscopy (2 Patients)
JejunumAPD = 2NORMALNORMAL-
IleumIleal Stricture (? TB) = 8Dilated Jejunal Coils6 Cases: Ileal Narrowing Dilated Small Bowel Loops6 Cases with Ileal Narrowing & Proximal Dilation
Carcinoma Caecum = 2Dilated Proximal Small Bowel2 Cases: Ileal Narrowing & Dilated Proximal Bowel
Small Bowel GIST = 2Dilated Proximal Small Bowel2 Cases: Cocoon of Ileal Loops at the IC Junction + Enlarged Lymph NodesFeatures Suggestive of Large Intestinal Obstruction at IC Junction

Intraoperatively, the more recent 8 patients were diagnosed to have carcinoid of the small intestine due to the experience gained from the previous 6 cases. All cases had solitary tumours of the small bowel. All showed desmoplasia of the mesentery with kinking of the small bowel. Ten patients underwent resection anastomosis of the tumour-bearing segment of small intestine with a minimum of 3cm clear surgical margins with removal of adjacent mesentery. Four of the 14 patients underwent right hemicolectomy due to the close proximity of the tumour to the ileo-caecal junction. Eight out of fourteen patients showed lymph node enlargement in the mesentery [Table/Fig-6]. The liver and peritoneum were normal in ten patients. In four patients who also had lymph node enlargement, liver metastases were found. None of the patients demonstrated features of carcinoid syndrome.

Resected bowel containing ileal carcinoid with cocooning of small intestinal loops (white arrow) that caused intestinal obstruction; excised mesenteric lymph node mass (yellow arrow)

The cut surface of gross specimen showed polypoidal type of lesions with stenosis of the affected segment in all cases. Histopathological examination confirmed carcinoid tumour of the small bowel in all the cases [Table/Fig-7]. There was lymph node metastasis in eight of them who had macroscopically enlarged lymph nodes in the mesentery and four of these patients additionally had liver metastases, which were confirmed on liver biopsy [Table/Fig-8]. Of these 4 patients with liver metastasis, 2 underwent metastasectomy as they were solitary, while only biopsy was done in the other two as they had multiple liver metastases.

Microscopy: H&E stained section showing tumour cells invading intestinal muscle coat (20X)

Microscopy: H&E stained section showing metastatic tumour cells in biopsied liver nodule (20X)

Postoperatively 24 hour urinary 5-hydroxy indole acetic acid (5HIAA) level was assessed and found to be normal in 12 patients while being mildly raised in two of them. All patients showed positivity for Chromogranin A on immunohistochemistry [Table/Fig-9]. Twelve patients recovered uneventfully and at a mean follow up of 4.3 years were found to be free of disease. Two of the patients died, 3 and 5 months respectively after right hemicolectomy due to inanition and intercurrent infection.

Operative procedure and postoperative investigations

Carcinoid SiteOperative Procedure PerformedPost-Operative Investigations
Diganostic Laproscopy with Open Resection AnastomosisLaprotomy and (1) Resection anastomosis + (2) Lymphadenectomy + (3) Liver Metastasectomy/Biospy24 Hour Urinary 5 - HIAAHistopathologyIHC for Chromogranin A
Jejunum2NormalJejunal CarcinoidPositive
Ileum(1) = 4 Patients(1) + (2) = 4 Patients(1) + (2) + (3) = 4PatientsMild Raise in 2 of 12 CasesNormal in 10 CasesIleal Carcinoid + Lymph Node Mets. in 8; Liver Mets. in 4Positive

Discussion

Carcinoid tumours of the small intestine are rare, slow growing neuroendocrine tumours arising from the enterochromaffin cells found in the crypts of Lieberkuhn. It gets its name from the fact that though benign it has carcinoma-like features microscopically [2]. The endocrine properties of carcinoid tumours were recognized in 1948 when Rapport et al., isolated and named Serotonin (5HT), as the vasoconstrictor substance in the serum. Lembeck identified Serotonin in an ileal carcinoid and confirmed it as the major hormone responsible for the Carcinoid syndrome [4,8]. The term enterochromaffin refers to the ability to stain with chromium or chrome salts in 5-HT containing cells. The term carcinoids in this era, is apt only for midgut i.e. small bowel carcinoids. The remaining carcinoid tumours should be termed neuro-endocrine tumours followed by their site of origin and the endocrinopathy that is present.

The incidence of carcinoid is increasing and this is thought to be largely due to the introduction of more sensitive diagnostic tools. The majority of the carcinoids are found within the gastrointestinal tract (55%) and bronchopulmonary system (30%) [7]. Population based statistics show that within the gastrointestinal tract, the small intestine is the most common site of carcinoids (45%) followed by rectum (20%), appendix (17%), colon (11%), stomach (7%). Far less common anatomical sites have been reported in literature, including breast, larynx, thymus and gall bladder [1417].

Carcinoid tumours account for highest percentage of small bowel tumours, representing approximately 1/3 of all small intestinal neoplasia [13], with 75% of small bowel carcinoids arising in the distal ileum within 60cm of the ileocaecal valve [9]. The incidence of these tumours increases with their proximity to the caecum. In our institution, the retrospective analysis found small bowel to be the commonest site of carcinoids (60%) and carcinoid tumours to be the commonest variety of small intestinal neoplasms (46.6%). Due to the indolent nature of these tumours, patients usually have non-specific symptoms for years before presenting late in the course of the disease when the diagnosis is made. Patients in the present series had symptoms ranging in duration from 1.5 to 10 years with a mean of 7 years. They present in the 6th or 7th decade of life and manifest with either intestinal colic or intermittent partial intestinal obstruction and are found to be locally advanced on laparotomy. In 40% of patients, carcinoids are discovered during emergency surgery for small bowel obstructions. Tumour infiltration into the mesentery provokes an intense fibrotic reaction (desmoplastic) that results in kinking of small bowel and resultant ischemia leading to small bowel obstruction [10]. In our series, 12 out of 14 patients (71.4%) had intermittent small intestinal obstruction, and in 8 patients (57%) carcinoid was recognized intraoperatively.

As non-specific as the initial symptoms of carcinoids may be, specific diagnostic techniques enable identification and localization of these tumours. Twenty-four hour urinary serotonin metabolite measurement is one such biochemical method used. Strodel et al., found elevated 5 HIAA (5-hydroxy indole acetic acid) in 24-hour urinary samples to be 100 percent specific and 73% sensitive for these cases. The combination of elevated platelet serotonin levels and urinary serotonin along with raised 5-HIAA leverls may be accurate in identifying carcinoids in nearly 84% of patients [8].

Locally advanced disease with typical mesenteric involvement can be identified on CT abdomen scans as an ill-defined mass at the root of mesentery with characteristic radiating dense soft tissue strands caused by thickened neurovascular bundles [18]. CT scan was done in ten patients who had a localized disease, but did not suggest a diagnosis of carcinoid. CT and MRI are equally effective at demonstrating regional and distant metastasis with a sensitivity of 77% and 80% respectively yet can underestimate the extent of disease in 25% of the cases.

Octreoscan has been found to be superior to that of cross sectional imaging with CT or MRI. Localisation of the tumour site with Indium -111 (In 111) labeled Octreotide (Somatostatin receptor scintigraphy) is helpful. The diagnostic sensitivity of octreoscan ranges between 80-90% [19]. It can also be used as a follow up tool.

Small bowel carcinoids are frequently multiple, exhibiting multicentricity in up to 30% of cases [8] though our series was composed of only solitary small bowel carcinoids. They often display metastases to the regional lymph nodes (39%) or the liver (31%) [8]. In our series, in 8 out of 14 cases (57%) regional lymph node metastasis was noted, with four of these having distant metastasis to the liver (28.5%). Percentage of patients with carcinoid syndrome is however only 5-7% [8,20]. It is commoner in younger patients in whom carcinoid tumours also have a more aggressive course. None of the patients in the study developed features of carcinoid syndrome, even on follow up, in spite of the presence of multiple metastases in two patients.

The preferred treatment remains radical surgical resection. The extent of resection depends on the size and location of the primary tumour. The resection of the small bowel primary with the mesenteric nodal disease is effective in relieving symptoms of gastrointestinal obstruction and was true in all the patients. This also leads to improved survival compared to patients in whom this cannot be achieved. An 83% 5-year survival rate has been described following surgery (cyto-reductive therapy) for the primary tumour [21]. All the patients in present series had localized or loco-regional disease and 12 out of 14 patients were disease free at a mean follow up of 4.3 years.

Carcinoid tumours are composed of small epithelioid cells, of low mitotic index with occasional acinar or rosette formation. Mixed tumours with acinar and glandular features have a median survival of 4.5 years and carry the best prognosis while poorly differentiated ones with the worst prognosis have a median survival of only 0.5 years. Nine of the cases (64.3%) had well differentiated tumours and the remaining 5 (35.7%) had moderately differentiated tumours. Diagnosis was additionally confirmed by immunohistochemical positivity for Chromogranin A which is the major granin expressed in gastric carcinoids and in serotonin producing carcinoids of the ileum and appendix. It is elevated in 85 to 100% of carcinoids regardless of functionality of the tumour [22]. All of our patients showed Chromogranin A positivity on immunohistochemistry.

Survival depends on stage or extent of carcinoid disease, tumour histology (grade), depth of tumour invasion and gender, race and age [5]. The Surveillance Epidemiology and End Results (SEER) Programme data showed overall 5-year and 10-year survival rates for well to moderately differentiated small bowel carcinoids to be 65% and 49% for localized disease, 71% and 46% for regional spread, and 54% and 30% for distant spread respectively [5].

Conclusion

Carcinoid tumours of the small bowel in southern India seems to be uncommon entity, compared to the Western population. In patients of the 5th decade or greater, with sub-acute intestinal obstruction or chronic abdominal pain, where intestinal tuberculosis is considered as a possible diagnosis, carcinoid tumours should be a differential diagnosis. Though the course of the disease is relatively benign, wide surgical resection of the lesion along with the mesentery and lymph nodes gives the best outcome. The diagnosis is often made intraoperatively on finding the presence of contraction and kinking of the mesentery due to desmoplastic reaction produced by the tumour. With the application of modern diagnostic tools such as CT and MRI in cases of chronic abdominal pain, it is possible that we will diagnose and identify these once thought to be elusive tumours more frequently than before.

Financial or Other Competing Interests

None.

References

[1]Lubarsch O, Ueberdemprimären Krebs des Ileum nebst Bemerkungenüber das gleichzeitigeVorkommen von Krebs und Tuberculose Virchows Arch Pathol Anat 1888 111:280-317.  [Google Scholar]

[2]Langhans T, Ubereinendrusenpolypimileum Virchow Archiv Pathol Anatom Phys Klin Med 1867 38:559-60.  [Google Scholar]

[3]Rapport MM, Green AA, Page IH, Serum vasoconstrictor, serotonin; isolation and characterization J BiolChem 1948 176:1243-51.  [Google Scholar]

[4]Lembeck F, 5-hydroxytryptamine in a carcinoid tumour Natur 1953 172:910-11.  [Google Scholar]

[5]Yao JC, Hassan M, Phan A, One hundred years after “carcinoid”: epidemiology of and prognosticfactors for neuroendocrine tumours in 35,825 cases in the United States J ClinOncol 2008 26:3063-72.  [Google Scholar]

[6]Gustafsson B, Kidd M, Modlin IM, Neuroendocrine tumours of the diffuse neuroendocrine system Curr Opin Oncol 2008 20:1-12.  [Google Scholar]

[7]Maggard MA, O’Connell JB, Ko CY, Updated population-based review of carcinoid tumours Ann Surg 2004 240:117-22.  [Google Scholar]

[8]Sippel RS, Chen H, Carcinoid Tumours Surg Oncol Clin N Am 2006 15:463-78.  [Google Scholar]

[9]Kulke M, Mayer R, Carcinoid tumours N Engl J Med 1999 340:858-68.  [Google Scholar]

[10]Pinchot SN, Holen K, Sippel RS, Chen H, Carcinoid tumours Oncologist 2008 13:1255-69.  [Google Scholar]

[11]Yamaguchi T, Manabe N, Tanaka S, Fukumoto A, Shimamoto M, Nakao M, Multiple carcinoid tumours of the ileum preoperatively diagnosed by enteroscopy with the double-balloon technique Gastrointest Endosc 2005 62:315-18.  [Google Scholar]

[12]Modlin IM, Lye KD, Kidd M, A 5-decade analysis of 13,715 carcinoid tumours Cancer 2003 97:934-959.  [Google Scholar]

[13]Modlin IM, Sandor A, An analysis of 8305 cases of carcinoid tumours Cancer 1997 79:813-29.  [Google Scholar]

[14]Ogawa H, Nishio A, Satake H, Neuroendcorine tumour of the breast Radiat Med 2008 26:28-32.  [Google Scholar]

[15]Giordano G, Corcione L, Giordano D, Primary moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: A case report with immunohistochemical and molecular study Auris Nasus Larynx 2009 36:228-31.  [Google Scholar]

[16]Vidal A, Lorenzo MJ, Isidro ML, Atypical thymic carcinoid in multiple endocrine neoplasiatype 1 syndrome J Endocrinol Invest 2007 30:601-02.  [Google Scholar]

[17]Anjaneyulu V, Shankar-Swamalatha G, Rao SC, Carcinoid tumour of the gallbladder Ann Diagn Pathol 2007 11:113-16.  [Google Scholar]

[18]Tamm EP, Kim EE, Ng CS, Imaging of neuroendocrine tumours Hematol Oncol Clin North Am 2007 21:409-32.  [Google Scholar]

[19]Kwekkeboom DJ, Krenning EP, Somatostatin receptor imaging Semin Nucl Med 2002 32:84-91.  [Google Scholar]

[20]Yantiss RK, Odze RD, Farraye FA, Solitary versus multiple carcinoid tumours of the ileum: aclinical and pathologic review of 68 cases Am J Surg Pathol 2003 27:811-17.  [Google Scholar]

[21]Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD, Current status of gastrointestinal carcinoids Gastroenterology 2005 128:1717-51.  [Google Scholar]

[22]Nehar D, Lombard–Bohas C, Olivieri S, Interest of chromogranin A for diagnosis and follow-up of endocrine tumours Clin Endocrinol 2004 60:644-52.  [Google Scholar]